Columbia Daily Tribune on MSN
Mizzou launches first trial of campus-made therapy for liver tumors
MU has launched its first clinical trial using reactor-made Eye90 microspheres to target inoperable liver tumors with precision radiotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results